|Bid||0.0000 x 29200|
|Ask||0.0000 x 1200|
|Day's range||3.9200 - 4.4384|
|52-week range||3.9200 - 28.8500|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||8.20|
Those following along with Clover Health Investments, Corp. ( NASDAQ:CLOV ) will no doubt be intrigued by the recent...
NASHVILLE, Tenn., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV), (“Clover Health”), a technology company committed to improving health equity for seniors, today announced the closing on November 22, 2021, of its previously announced underwritten public offering of shares of its Class A Common Stock, resulting in approximately $300 million of gross proceeds. In connection with the offering, Clover also granted the underwriters a 30-day option to purchase up to
Ingenovis Health CEO Bart Valdez joins Yahoo Finance to discuss the nursing shortage and what can be done to create better conditions for both nurses and patients.